The University of Louisville School of Medicine at the University of Louisville is a medical school located in Louisville, Kentucky, United States. Opened as the Louisville Medical Institute in 1837, it is one of the oldest medical schools in North America and the 9th oldest in the United States.

During the past decade, University of Louisville School of Medicine conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 6 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 3 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Louisville School of Medicine" #1 sponsor was "University of Louisville" with 3 trials, followed by "AMAG Pharmaceuticals, Inc." with 1 trials sponsored, "Abiomed Inc." with 1 trials sponsored, "Actelion" with 1 trials sponsored and "Bio-Pharm Solutions Co., Ltd." with 1 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Louisville School of Medicine" #1 collaborator was "Beth Israel Deaconess Medical Center" with 1 trials as a collaborator, "Boston Children's Hospital" with 1 trials as a collaborator, "Brown University" with 1 trials as a collaborator, "Canadian Heart Research Centre" with 1 trials as a collaborator and "Childhood Arthritis and Rheumatology Research Alliance" with 1 trials as a collaborator. Other collaborators include 20 different institutions and companies that were collaborators in the rest 30 trials.

According to Clinical.Site data, the most researched conditions in "University of Louisville School of Medicine" are "Crohn's Disease" (2 trials), "Acute Respiratory Failure" (1 trials), "Age Related Macular Degeneration" (1 trials), "Anorectal Fistula" (1 trials) and "Arthritis, Juvenile Idiopathic" (1 trials). Many other conditions were trialed in "University of Louisville School of Medicine" in a lesser frequency.

Most popular intervention types in "University of Louisville School of Medicine" are "Drug" (10 trials), "Device" (4 trials), "Behavioral" (2 trials), "Dietary Supplement" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "ABIOMED, Inc. hemodynamic support devices" (1 trials), "ASQ-3, Bayley III, Neurologic exam" (1 trials), "Bronchoscope disposable (aScope 4)" (1 trials) and "Bronchoscope reusable (Storz 8402 2x)" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Louisville School of Medicine" are 19 trials for "All" genders.

Currently, there are NaN active trials in "University of Louisville School of Medicine". 1 are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in University of Louisville School of Medicine, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in University of Louisville School of Medicine, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 5 trials that are defined as “Not Applicable".